These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18234966)

  • 1. Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation.
    Wang Y; Zhang Z; Lu Y; Yao R; Jia D; Wen W; LaRegina M; Crist K; Lubet R; You M
    Mol Cancer Res; 2008 Jan; 6(1):99-109. PubMed ID: 18234966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.
    Zhang Z; Wang Y; Yao R; Li J; Lubet RA; You M
    Mol Cancer Res; 2006 Jun; 4(6):401-10. PubMed ID: 16778087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression in the lung of p53 mutant mice exposed to cigarette smoke.
    Izzotti A; Cartiglia C; Longobardi M; Bagnasco M; Merello A; You M; Lubet RA; De Flora S
    Cancer Res; 2004 Dec; 64(23):8566-72. PubMed ID: 15574763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
    Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
    Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
    De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
    Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical studies of recessive oncogene p53 and N-myc oncogene expression in 7, 12 dimethylbenz (a) anthracene-induced rat ovarian tumors].
    Kataoka A; Nishida T; Sugiyama T; Hirakawa N; Maruuchi T; Imaishi K; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Apr; 44(4):391-6. PubMed ID: 1318915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
    Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
    Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
    Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR
    Cancer Cell; 2007 Apr; 11(4):321-33. PubMed ID: 17418409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.
    Zhang Z; Li J; Lantry LE; Wang Y; Wiseman RW; Lubet RA; You M
    Cancer Res; 2002 Jun; 62(11):3024-9. PubMed ID: 12036908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
    Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
    J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control.
    Pollock R; Lang A; Ge T; Sun D; Tan M; Yu D
    Clin Cancer Res; 1998 Aug; 4(8):1985-94. PubMed ID: 9717829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors.
    L'Espérance S; Popa I; Bachvarova M; Plante M; Patten N; Wu L; Têtu B; Bachvarov D
    Int J Oncol; 2006 Jul; 29(1):5-24. PubMed ID: 16773180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
    Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
    Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency.
    Hollander MC; Kovalsky O; Salvador JM; Kim KE; Patterson AD; Haines DC; Fornace AJ
    Cancer Res; 2001 Mar; 61(6):2487-91. PubMed ID: 11289119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis.
    Nicol CJ; Yoon M; Ward JM; Yamashita M; Fukamachi K; Peters JM; Gonzalez FJ
    Carcinogenesis; 2004 Sep; 25(9):1747-55. PubMed ID: 15073042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture.
    Crist KA; Zhang Z; You M; Gunning WT; Conran PB; Steele VE; Lubet RA
    Carcinogenesis; 2005 May; 26(5):951-7. PubMed ID: 15695234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid induction of ovarian granulosa cell tumors by 7,12-dimethylbenz(a)anthracene in neonatally estrogenized mice.
    Taguchi O; Michael SD; Nishizuka Y
    Cancer Res; 1988 Jan; 48(2):425-9. PubMed ID: 3121173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
    Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
    Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor formation in p53 mutant ovaries transplanted into wild-type female hosts.
    Chen CM; Chang JL; Behringer RR
    Oncogene; 2004 Oct; 23(46):7722-5. PubMed ID: 15334065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.